PureTech Health plc - ROE
PRTC
Price:
$17.31
Market Cap:
$421.39M
PureTech Health plc operates as a clinical-stage biotherapeutics company, dedicated to the discovery, advancement, and market introduction of innovative medicines. The firm's therapeutic focus spans a broad range of challenging conditions, including inflammatory, fibrotic, and immunological disorders, various intractable cancers, lymphatic and gastrointestinal ailments, and a spectrum of neurological and neuropsychological diseases, primarily serving the United States market. The company's diverse portfolio features advanced programs, such as KarXT, which targets muscarinic acetylcholine receptors to treat schizophrenia and psychosis associated with Alzheimer's disease. PureTech also leverag...[Read more]
Industry
Biotechnology
IPO Date
2020-11-16
Stock Exchange
NASDAQ
Ticker
PRTC
PE Ratio
[-3.76]
ROE
[-31.83%]
Current Ratio
[6.59]
Dividend Yield
[0%]
Enterprise Value
[186.91M]
Dividend History
The ROE as of June 2026 (TTM) for PureTech Health plc (PRTC) is -31.83%
According to PureTech Health plc’s latest financial reports and current stock price. The company's current ROE is -31.83%. This represents a change of 455.80% compared to the average of -5.73% of the last 4 quarters.
PureTech Health plc (PRTC) Historical ROE (quarterly & annually)
How has PRTC ROE performed in the past?
The mean historical ROE of PureTech Health plc over the last ten years is -2.09%. The current -31.83% ROE has changed 1.42% with respect to the historical average. Over the past ten years (40 quarters), PRTC's ROE was at its highest in in the December 2013 quarter at 243.38%. The ROE was at its lowest in in the June 2013 quarter at -194.71%.
Average
-2.09%
Median
-9.75%
Minimum
-35.16%
Maximum
63.04%
PureTech Health plc (PRTC) ROE by Quarter and Year
Discovering the peaks and valleys of PureTech Health plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 57.64%
Maximum Annual ROE = 63.04%
Minimum Annual Increase = -1241.79%
Minimum Annual ROE = -35.16%
| Year | ROE | Change |
|---|---|---|
| 2025 | -35.16% | -372.53% |
| 2024 | 12.90% | -191.14% |
| 2023 | -14.16% | 52.44% |
| 2022 | -9.29% | -8.98% |
| 2021 | -10.20% | -1241.79% |
| 2020 | 0.89% | -98.58% |
| 2019 | 63.04% | -497.87% |
| 2018 | -15.84% | -210.00% |
| 2017 | 14.40% | -152.45% |
| 2016 | -27.46% | 57.64% |
PureTech Health plc (PRTC) Average ROE
How has PRTC ROE performed in the past?
The current ROE of PureTech Health plc (PRTC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-12.14%
5-year avg
-11.18%
10-year avg
-2.09%
PureTech Health plc (PRTC) ROE vs. Peers
How is PRTC’s ROE compared to its peers?
PureTech Health plc’s ROE is greater than Autolus Therapeutics plc (-128.53%), greater than Neurogene Inc. (-37.88%), greater than Solid Biosciences Inc. (-74.45%), greater than Quantum-Si incorporated (-47.35%), greater than Lineage Cell Therapeutics, Inc. (-152.10%), greater than Benitec Biopharma Inc. (-34.82%), less than ADC Therapeutics S.A. (65.27%), greater than Alumis Inc. Common Stock (-54.63%), greater than Rocket Pharmaceuticals, Inc. (-70.79%), greater than Neumora Therapeutics, Inc. Common Stock (-181.70%),
| Company | ROE | Market cap |
|---|---|---|
| -128.53% | $401.88M | |
| -37.88% | $498.23M | |
| -74.45% | $648.99M | |
| -47.35% | $197.62M | |
| -152.10% | $301.65M | |
| -34.82% | $318.90M | |
| 65.27% | $138.64M | |
| -54.63% | $2.89B | |
| -70.79% | $365.80M | |
| -181.70% | $279.78M |
Build a custom stock screener for PureTech Health plc (PRTC) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PureTech Health plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
PureTech Health plc (PRTC) and other stocks custom spreadsheet templates
The easiest way to analyze a company like PureTech Health plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is PureTech Health plc's ROE?
How is the ROE calculated for PureTech Health plc (PRTC)?
What is the highest ROE for PureTech Health plc (PRTC)?
What is the 3-year average ROE for PureTech Health plc (PRTC)?
What is the 5-year average ROE for PureTech Health plc (PRTC)?
How does the current ROE for PureTech Health plc (PRTC) compare to its historical average?